SGMO icon

Sangamo Therapeutics

205 hedge funds and large institutions have $691M invested in Sangamo Therapeutics in 2020 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 77 increasing their positions, 47 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
205
Holders Change
+15
Holders Change %
+7.89%
% of All Funds
4.21%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
31
Increased
77
Reduced
47
Closed
15
Calls
$15.5M
Puts
$10.5M
Net Calls
+$4.97M
Net Calls Change
+$3.77M
Name Holding Trade Value Shares
Change
Shares
Change %
OSAM
201
O'Shaughnessy Asset Management
Connecticut
$1K +$1K +58 New
ECM
202
Estabrook Capital Management
New York
$125
TI
203
tru Independence
Oregon
$9
EC
204
EcoR1 Capital
California
-$14.7M -2,308,079 Closed
Millennium Management
205
Millennium Management
New York
-$9.48M -1,488,020 Closed
Marshall Wace
206
Marshall Wace
United Kingdom
-$8.68M -1,363,039 Closed
3C
207
361 Capital
Colorado
-$695K -109,161 Closed
Balyasny Asset Management
208
Balyasny Asset Management
Illinois
-$592K -92,994 Closed
Squarepoint
209
Squarepoint
New York
-$339K -53,294 Closed
MWM
210
Merriman Wealth Management
Washington
-$166K -26,000 Closed
Capital Fund Management (CFM)
211
Capital Fund Management (CFM)
France
-$164K -25,822 Closed
CM
212
Caption Management
Oklahoma
-$160K -25,000 Closed
MAM
213
Martingale Asset Management
Massachusetts
-$122K -19,050 Closed
BFM
214
Boothbay Fund Management
New York
-$71K -11,100 Closed
ASN
215
Advisory Services Network
Georgia
-$1K -200 Closed